Breaking

McIntosh: Midterms a choice between Trump’s ‘great progress’ and ‘socialists back in’
After her father’s addiction led to a $91K gambling spiral, GOP Rep Erin Houchin pushes addiction reform
Iran regime cited as Trump admin set to designate Sudan’s Muslim Brotherhood a terror group
Putin caught executing enormous ‘semi-dark’ ship-to-ship oil transfer in Gulf of Oman
DOJ blasts ‘partisan’ DC Bar complaint against senior Trump official
US strike on key Iran oil hub would fit Trump’s ‘energy dominance doctrine,’ expert says
Speaker Johnson touts Trump’s agenda as crucial blueprint ahead of midterms: ‘On the ballot’
Rubio designates Afghanistan as ‘state sponsor of wrongful detention’: ‘Despicable tactics’

Business
World
Investing
Politics
Search for:

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0

admin

Website

Related Posts

Earthwise Engages Global One Media

Tavi Costa: Gold, Silver Stocks to Rerate, “Explosive” Energy, Copper Opportunities

Drill Contract Awarded for Two Pools Maiden Drill Program

Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (770)
- Investing (3,862)
- Politics (4,693)
- World (2,544)

Disclaimer: ventureblessing.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2026 ventureblessing.com | All Rights Reserved

Top

Business
World
Investing
Politics

Type above and press Enter to search. Press Esc to cancel.